Development of a regulatable oncolytic herpes simplex virus type 1 recombinant virus for tumor therapy.
about
Recent advances in oncolytic virus design.Effect of a caspase inhibitor, zVADfmk, on the inhibition of breast cancer cells by herpes simplex virus type 1.A haploid HSV-1 genome platform for vector development: testing of the tetracycline-responsive switch shows interference by infected cell protein 0.
P2860
Development of a regulatable oncolytic herpes simplex virus type 1 recombinant virus for tumor therapy.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Development of a regulatable o ...... inant virus for tumor therapy.
@ast
Development of a regulatable o ...... inant virus for tumor therapy.
@en
Development of a regulatable o ...... inant virus for tumor therapy.
@nl
type
label
Development of a regulatable o ...... inant virus for tumor therapy.
@ast
Development of a regulatable o ...... inant virus for tumor therapy.
@en
Development of a regulatable o ...... inant virus for tumor therapy.
@nl
prefLabel
Development of a regulatable o ...... inant virus for tumor therapy.
@ast
Development of a regulatable o ...... inant virus for tumor therapy.
@en
Development of a regulatable o ...... inant virus for tumor therapy.
@nl
P2093
P2860
P356
P1433
P1476
Development of a regulatable o ...... inant virus for tumor therapy.
@en
P2093
Nao Murakami
Natali V Akhrameyeva
Oliver Bleiziffer
Pengwei Zhang
Richard Brans
P2860
P304
P356
10.1128/JVI.00059-10
P407
P577
2010-06-02T00:00:00Z